1. P392: PHARMACOLOGICAL INHIBITION OF SYK CONFERS ANTI-PROLIFERATIVE AND NOVEL ANTI-TUMOR IMMUNE RESPONSES IN AML. (23rd June 2022) Authors: Carvajal, L. A.; Robinson, B.; Kosaka, Y.; Jacob, T.; Lee, J.; Hood, T.; Baker, K.; Kaempf, A.; Amara, S. N.-A.; Pucilowska, J.; Lind, E.; Tognon, C.; Tyner, J.; Kumar, P.; Vu, T.; DiMartino, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗